Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 94, 2012
Previous Article Next Article

Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

Author affiliations

Abstract

Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.

Graphical abstract: Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

Back to tab navigation

Supplementary files

Article information


Submitted
04 Sep 2012
Accepted
12 Oct 2012
First published
18 Oct 2012

Chem. Commun., 2012,48, 11567-11569
Article type
Communication

Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy

G. Fu, W. Liu, S. Feng and X. Yue, Chem. Commun., 2012, 48, 11567
DOI: 10.1039/C2CC36456E

Social activity

Search articles by author

Spotlight

Advertisements